SCHEMBL8249142

SCHEMBL8249142

CCOC(=O)C1(C(=O)O)CCCN1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.41
SMN1; SMN2 Q16637 2/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
ALOX15 P16050 1/20 0.36
POLB P06746 1/20 0.36
OPRD1 P41143 3/20 0.34
OPRK1 P41145 3/20 0.34
SLC6A4 P31645 2/20 0.34
SLC22A1 O15245 1/20 0.34
ADRA1A P35348 1/20 0.34
KCNH2 Q12809 1/20 0.34
GAA P10253 1/20 0.33
ARG1 P05089 1/20 0.33
ARG2 P78540 1/20 0.33
LMNA P02545 1/20 0.32
KCNA3 P22001 1/20 0.32
SLC6A2 P23975 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL337356 0.91 OPRM1 (0.41) OPRM1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL9374437 0.80 OPRM1 (0.39) OPRM1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL7811721 0.80 MEN1 (0.40) SMN1; SMN2MEN1KMT2APOLBKCNH2
SCHEMBL7815568 0.80 MEN1 (0.40) SMN1; SMN2MEN1KMT2APOLBKCNH2
SCHEMBL8764177 0.80 MEN1 (0.40) SMN1; SMN2MEN1KMT2APOLBKCNH2
SCHEMBL774037 0.77 ARG1 (0.39) ARG1ARG2
SCHEMBL7313574 0.76 CYP4F2 (0.31) ARG1ARG2
SCHEMBL10670488 0.75 DDB1 (0.49) KMT2ASLC6A2SLC6A3
SCHEMBL10957286 0.75 OPRM1 (0.40) OPRM1SMN1; SMN2MEN1KMT2AKDM4E
SCHEMBL28426667 0.75 OPRM1 (0.40) OPRM1SMN1; SMN2MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2336136-A1 Pyridine derivatives and their use in the treatment of psychotic disorders GlaxoSmithKline LLC (US) 2011-06-22 EP disclosed
WO-2007028654-A1 PYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS SMITHKLINE BEECHAM CORPORATION (US) 2007-03-15 WO disclosed